[Source: Fierce Pharma ] January 2025 The FDA fast-tracked tirzepatide for cardiovascular risk reduction in obesity patients, following landmark trial results showing significant benefit beyond weight loss
It is high in vitamins A, B, B3 (niacin), C, D, and E
This extends half-life from minutes to ~165 hours, allowing weekly administration in research
Alla fine del periodo di studio di 56 settimane, nei bracci dei pazienti trattati con liraglutide si registrato non solo un calo ponderale significativo, ma anche la riduzione del rapporto albumina/creatinina urinarie (UACR) nella misura del 18,36, 10,79 e del 2,34%, rispettivamente
Comparing Cost and Accessibility: GLP-1 Medication vs Lifestyle Approach When GLP-1 Medications May Still Make Sense GLP-1 therapy can be an appropriate option in certain situations, including: Significant obesity Type 2 diabetes or other metabolic conditions When lifestyle approaches alone have not been sufficient As part of a broader strategy that includes sustainable dietary and lifestyle changes For some individuals, these medications may serve as a starting point, with long-term success depending on how metabolic health is supported over time